Intensivmedizin up2date, Table of Contents Intensivmedizin up2date 2023; 19(03): 349-367DOI: 10.1055/a-2146-1929 Operative Intensivmedizin Intensivtherapie in der Herzchirurgie – alles anders? Authors Bernd Panholzer Veronika Walter Christopher Jakobi Michael Stöck Berthold Bein Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Jährlich werden in Deutschland ca. 100000 herzchirurgische Operationen [1] durchgeführt: Somit zählen diese zu den häufigsten mit einer Intensivtherapie verbundenen Eingriffen. Der Intensivaufenthalt kann sich aufgrund der Invasivität der Eingriffe, der mitunter schwerwiegenden Grunderkrankung und der häufigen Begleiterkrankungen der zunehmend älteren Patienten unter Umständen auch komplex gestalten. Schlüsselwörter SchlüsselwörterHerzchirurgie - hämodynamisches Monitoring - kardiogener Schock - Herzrhythmusstörungen - Myokardinfarkt - Patient Blood Management Full Text References Literatur 1 Beckmann A, Meyer R, Lewandowski J. et al. German heart surgery report 2020: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2021; 69: 294-307 2 Habicher M, Zajonz T, Heringlake M. et al. S3-Leitlinie zur intensivmedizinischen Versorgung herzchirurgischer Patienten: Hämodynamisches Monitoring und Herz-Kreislauf – ein Update. Anaesthesist 2018; 67: 375-379 3 Evans L, Rhodes A, Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 2021; 49: 1974-1982 4 Janssens U, Jung C, Hennersdorf M. et al. Empfehlungen zum hämodynamischen Monitoring in der internistischen Intensivmedizin. Kardiologe 2016; 10: 149-169 5 Bodys-Pelka A, Kusztal M, Boszko M. et al. Non-invasive continuous measurement of haemodynamic parameters—clinical utility. J Clin Med 2021; 10: 4929 6 Trauzeddel RF, Nordine M, Groesdonk HV. et al. Perioperative Optimierung mittels auf die Hämodynamik fokussierter Echokardiografie bei Hochrisikopatienten – eine Praxisanleitung. Anaesthesist 2021; 70: 772-784 7 Humbert M, Kovacs G, Hoeper MM. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43: 3618-3731 8 Pilarczyk K, Haneya A, Panholzer B. Hämodynamisches Monitoring nach herzchirurgischem Eingriff. Z Herz Thorax Gefäßchir 2022; 36: 225-239 9 McDonagh TA, Metra M, Adamo M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart 2021; 42: 4901 10 Hajjar LA, Vincent JL, Barbosa Gomes Galas FR. et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery. Anesthesiology 2017; 126: 85-93 11 Currigan DA, Hughes RJA, Wright CE. et al. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries. Anesthesiology 2014; 121: 930-936 12 Lewis TC, Aberle C, Altshuler D. et al. Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock. J Cardiovasc Pharmacol Ther 2019; 24: 130-138 13 Guarracino F, Heringlake M, Cholley B. et al. Use of levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol 2018; 71: 1-9 14 Horwitz SMC, Kelleher K, Thomas Boyce PMT. et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507 15 Harber CR, Sosnowski KJ, Hegde RM. Highly conservative phlebotomy in adult intensive care–a prospective randomized controlled trial. Anaesth Intensive Care 2006; 34: 434-437 16 Bein B, Schiewe R. Kardioanästhesie: Monitoring der Gerinnung und Gerinnungstherapie. Anästhesiol Intensivmed Notfallmed Schmerzther 2018; 53: 364-379 17 van Diepen S, Mehta RH, Leimberger JD. et al. Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. J Thorac Cardiovasc Surg 2020; 159: 2302-2309.e6 18 Caruba T, Charles-Nelson A, Alexander JH. et al. Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: a pooled analysis of two multicentre randomised controlled trials. Anaesth Crit Care Pain Med 2022; 41: 101107 19 Panholzer B, Haneya A. Kunstherzpatienten im Rettungswesen. Notfallmedizin up2date 2017; 12: 63-76 20 Lopes LA, Agrawal DK. Post-operative atrial fibrillation: current treatments and etiologies for a persistent surgical complication. J Surg Res 2022; 5: 159-172 21 Maesen B, Nijs J, Maessen J. et al. Post-operative atrial fibrillation: a maze of mechanisms. Europace 2012; 14: 159-174 22 Bidar E, Bramer S, Maesen B. et al. Post-operative atrial fibrillation – pathophysiology, treatment and prevention. J Atr Fibrillation 2013; 5: 781 23 Hindricks G, Potpara T, Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42: 373-498 24 Poelzl G, Birgani SA, Comin-Colet J. et al. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period. ESC Heart Fail 2019; 6: 174-181 25 Muehlschlegel JD, Burrage PS, Ngai JY. et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists practice advisory for the management of perioperative atrial fibrillation in patients undergoing cardiac surgery. Anesth Analg 2019; 128: 33-42 26 Gibb S, Rehberg S. The role of the ultra short-acting β1-adrenoreceptor antagonist Landiolol in the treatment of atrial fibrillation: pharmacology, clinical application and current evidence in anaesthesiology, intensive care and emergency medicine. Anästh Intensivmed 2018; 59: 407-421 27 Fellahi J-L, Heringlake M, Knotzer J. et al. Landiolol for managing atrial fibrillation in post-cardiac surgery. Eur Heart J 2018; 20: A4-A9 28 Nashef AMS, Roques F, Sharples LD. et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41: 734-744 29 Thygesen K, Alpert JS, Jaffe AS. et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72: 2231-2264 30 Niclauss L, Pfister R, Delay D. et al. Usefulness of postoperative high-sensitive troponin T measurement and implications for defining type 5 infarction. J Card Surg 2022; 37: 151-161 31 Devereaux PJ, Lamy A, Chan MTV. et al. High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality. N Engl J Med 2022; 386: 827-836 32 Omram H, Deutsch MA, Groenzinger E. et al. High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making. Eur Heart J 2022; 43: 2388-2403 33 Universitätsklinikum Frankfurt. Patient Blood Management. Accessed January 23, 2023 at: https://www.patientbloodmanagement.de/ 34 Gombotz H, Hofmann A. Patient Blood Management Dreisäulenstrategie zur Verbesserung des Outcomes durch Vermeidung allogener Blutprodukte. Anaesthesist 2013; 62: 519-527 35 Koch CG, Li L, Sun Z. et al. Hospital-acquired anemia: prevalence, outcomes, and healthcare implications. J Hosp Med 2013; 8: 506-512 36 Lobel GP, Javidroozi M, Shander A. Risks of anemia in cardiac surgery patients. Semin Cardiothorac Vasc Anesth 2015; 19: 288-292 37 Meybohm P, Choorapoikayil S, Zacharowski K. Patient Blood Management in der Intensivmedizin. Intensivmedizin up2date 2017; 13: 291-307 38 Tankard KA, Park B, Brovman EY. et al. The impact of preoperative intravenous iron therapy on perioperative outcomes in cardiac surgery: a systematic review. J Hematol 2020; 9: 97-108 39 Spahn DR, Schoenrath F, Spahn GH. et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet 2019; 393: 2201-2212 40 Lasocki S, Pène F, Ait-Oufella H. et al. Management and prevention of anemia (acute bleeding excluded) in adult critical care patients. Ann Intensive Care 2020; 10: 97 41 Harber CR, Sosnowski KJ, Hegde RM. Highly conservative phlebotomy in adult intensive care--a prospective randomized controlled trial. Anaesth Intensive Care 2006; 34: 434-437 42 Lyon AW, Chin AC, Slotsve GA. et al. Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model. Comput Biol Med; 2013; 43: 84-90 43 van Diepen S, Katz JN, Albert NM. et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 2017; 136: e232-e268 44 Goulden CJ, Hagana A, Ulucay E. et al. Optimising risk factors for atrial fibrillation post-cardiac surgery. Perfusion 2022; 37: 675-683 45 Pesonen E, Vlasov H, Suojaranta R. et al. Effect of 4% albumin solution vs ringer acetate on major adverse events in patients undergoing cardiac surgery with cardiopulmonary bypass. A randomized clinical trial. JAMA 2022; 328: 251-258 46 Thang C, Marella P, Kumar A. et al. Early albumin exposure after cardiac surgery. J Cardiothorac Vasc Anesth 2022; 36: 1310-1317
